RAPT(Delisted)
RAPT Therapeutics·NASDAQ
--
--(--)
8.48 / 10
Outperform
The company's fundamentals are exceptionally strong, evidenced by an 8.5/10 score. Positive aspects include a high interest coverage ratio (15.65) and a favorable PB-ROE difference (19.48), indicating solid profitability and capital efficiency. Growth is robust with operating revenue up 92.51% YoY. However, accounts receivable turnover (25.75) and inventory turnover (47.80) are suboptimal, suggesting room for improvement in working capital management. Days sales outstanding (72.62) is elevated, aligning with weaker receivable efficiency. Overall, the balance sheet and earnings power remain healthy, supporting an Outperform stance.
Analysis Checks(5/10)
Total operating revenue (YoY growth rate %)
Value78.31
Score2/3
Weight0.86%
1M Return0.16%
Value78.31
Score2/3
Weight0.86%
1M Return0.16%
Inventory turnover ratio
Value47.79
Score1/3
Weight-6.71%
1M Return-1.31%
Value47.79
Score1/3
Weight-6.71%
1M Return-1.31%
PB-ROE
Value19.48
Score3/3
Weight85.98%
1M Return11.93%
Value19.48
Score3/3
Weight85.98%
1M Return11.93%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.65
Score2/3
Weight-4.36%
1M Return-0.83%
Value15.65
Score2/3
Weight-4.36%
1M Return-0.83%
Cost of sales ratio (%)
Value70.39
Score1/3
Weight-7.73%
1M Return-1.52%
Value70.39
Score1/3
Weight-7.73%
1M Return-1.52%
Days sales outstanding
Value72.62
Score1/3
Weight-7.78%
1M Return-1.52%
Value72.62
Score1/3
Weight-7.78%
1M Return-1.52%
Accounts receivable turnover ratio
Value25.75
Score1/3
Weight-5.09%
1M Return-0.98%
Value25.75
Score1/3
Weight-5.09%
1M Return-0.98%
Income tax / Total profit (%)
Value-5.62
Score0/3
Weight-9.84%
1M Return-1.94%
Value-5.62
Score0/3
Weight-9.84%
1M Return-1.94%
Operating revenue (YoY growth rate %)
Value92.51
Score2/3
Weight1.39%
1M Return0.25%
Value92.51
Score2/3
Weight1.39%
1M Return0.25%
Asset-MV
Value-0.49
Score2/3
Weight53.27%
1M Return7.15%
Value-0.49
Score2/3
Weight53.27%
1M Return7.15%
Total operating revenue (YoY growth rate %)
Value78.31
Score2/3
Weight0.86%
1M Return0.16%
Value78.31
Score2/3
Weight0.86%
1M Return0.16%
Days sales outstanding
Value72.62
Score1/3
Weight-7.78%
1M Return-1.52%
Value72.62
Score1/3
Weight-7.78%
1M Return-1.52%
Inventory turnover ratio
Value47.79
Score1/3
Weight-6.71%
1M Return-1.31%
Value47.79
Score1/3
Weight-6.71%
1M Return-1.31%
Accounts receivable turnover ratio
Value25.75
Score1/3
Weight-5.09%
1M Return-0.98%
Value25.75
Score1/3
Weight-5.09%
1M Return-0.98%
PB-ROE
Value19.48
Score3/3
Weight85.98%
1M Return11.93%
Value19.48
Score3/3
Weight85.98%
1M Return11.93%
Income tax / Total profit (%)
Value-5.62
Score0/3
Weight-9.84%
1M Return-1.94%
Value-5.62
Score0/3
Weight-9.84%
1M Return-1.94%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.65
Score2/3
Weight-4.36%
1M Return-0.83%
Value15.65
Score2/3
Weight-4.36%
1M Return-0.83%
Operating revenue (YoY growth rate %)
Value92.51
Score2/3
Weight1.39%
1M Return0.25%
Value92.51
Score2/3
Weight1.39%
1M Return0.25%
Cost of sales ratio (%)
Value70.39
Score1/3
Weight-7.73%
1M Return-1.52%
Value70.39
Score1/3
Weight-7.73%
1M Return-1.52%
Asset-MV
Value-0.49
Score2/3
Weight53.27%
1M Return7.15%
Value-0.49
Score2/3
Weight53.27%
1M Return7.15%
Is RAPT undervalued or overvalued?
- RAPT scores 8.48/10 on fundamentals and holds a Discounted valuation at present. Backed by its -30.65% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 47.67% earnings growth, these metrics solidify its Outperform investment rating.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
